Emmanuel Olumuyide, Ezaz Rahman, Shengnan Zheng, Mefri Yanni, Ehimen Aneni, Bruce Samuels, Jiun-Ruey Hu
{"title":"Clinical outcomes of anemia in patients with spontaneous coronary artery dissection: a retrospective cohort analysis.","authors":"Emmanuel Olumuyide, Ezaz Rahman, Shengnan Zheng, Mefri Yanni, Ehimen Aneni, Bruce Samuels, Jiun-Ruey Hu","doi":"10.1007/s11239-026-03314-3","DOIUrl":null,"url":null,"abstract":"<p><p>Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndrome, especially in younger patients and women. Anemia, a common comorbidity in patients with cardiovascular disease, may modulate outcomes in SCAD, but its influence remains poorly defined. We identified adult hospitalizations for SCAD in the Nationwide Inpatient Sample (2016-2022), stratified by anemia status. Multivariable logistic regression models were constructed to examine the relationship between anemia and in-hospital outcomes, while adjusting for demographics, comorbidities, and hospital characteristics. The primary outcome was all-cause in-hospital mortality. Secondary outcomes included cardiac arrest (CA), mechanical circulatory support (MCS), cardiogenic shock (CS), heart failure reduced ejection fraction (HFrEF), heart failure preserved ejection fraction (HFpEF), blood transfusion (BT), vasopressor use (VU), mechanical ventilation (MV), acute kidney injury (AKI), atrial fibrillation (AF), length of stay (LOS) and total hospital charges (THC). Among 63,450 SCAD hospitalizations, 24.8% had comorbid anemia. Patients with anemia were older (63.4 vs. 59.7 years) and had a higher comorbidity burden. While no significant difference in in-hospital mortality was observed (10.8% vs. 4.6%; adjusted odds ratio [aOR] 1.15, 95% confidence interval [CI]: 0.96-1.38; p = 0.115), anemia was associated with significantly greater odds of MCS (28.2% vs. 9.5%; aOR 2.64, CI: 2.34-2.99; p < 0.001), CS (23.5% vs. 6.9%; aOR 2.27, CI: 1.98-2.61; p < 0.001), HFrEF (20.7% vs. 12.1%; aOR 0.99, CI: 0.88-1.14; p = 0.324), HFpEF (8.8% vs. 4.3%; aOR 1.26, CI: 1.04-1.52; p = 0.020), VU (9.3% vs. 2.1%; aOR 2.56, CI: 2.04-3.20; p < 0.001) AKI (33.2% vs. 9.5%; aOR 2.28, CI: 2.02-2.59; p < 0.001) AF (27.0% vs. 12.9%; aOR 1.74, CI: 1.55-1.97; p < 0.001) BT (17.8% vs. 1.3%; aOR 12.71, CI: 10.07-16.04; p < 0.001). Anemia was associated with increased hospital length of stay (LOS) (10 vs. 4 days; β = 3.9; p < 0.001) and higher THC ($285,660 vs. $114,861; β = $117,902; p < 0.001). Among patients hospitalized with SCAD, anemia was associated with higher risks of hemodynamic compromise, acute kidney injury, atrial fibrillation, and greater resource utilization, although mortality differences were not statistically significant. Recognition of anemia may help identify high-risk SCAD patients needing closer monitoring and tailored management.</p>","PeriodicalId":17546,"journal":{"name":"Journal of Thrombosis and Thrombolysis","volume":" ","pages":"1459-1466"},"PeriodicalIF":2.1000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thrombosis and Thrombolysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11239-026-03314-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndrome, especially in younger patients and women. Anemia, a common comorbidity in patients with cardiovascular disease, may modulate outcomes in SCAD, but its influence remains poorly defined. We identified adult hospitalizations for SCAD in the Nationwide Inpatient Sample (2016-2022), stratified by anemia status. Multivariable logistic regression models were constructed to examine the relationship between anemia and in-hospital outcomes, while adjusting for demographics, comorbidities, and hospital characteristics. The primary outcome was all-cause in-hospital mortality. Secondary outcomes included cardiac arrest (CA), mechanical circulatory support (MCS), cardiogenic shock (CS), heart failure reduced ejection fraction (HFrEF), heart failure preserved ejection fraction (HFpEF), blood transfusion (BT), vasopressor use (VU), mechanical ventilation (MV), acute kidney injury (AKI), atrial fibrillation (AF), length of stay (LOS) and total hospital charges (THC). Among 63,450 SCAD hospitalizations, 24.8% had comorbid anemia. Patients with anemia were older (63.4 vs. 59.7 years) and had a higher comorbidity burden. While no significant difference in in-hospital mortality was observed (10.8% vs. 4.6%; adjusted odds ratio [aOR] 1.15, 95% confidence interval [CI]: 0.96-1.38; p = 0.115), anemia was associated with significantly greater odds of MCS (28.2% vs. 9.5%; aOR 2.64, CI: 2.34-2.99; p < 0.001), CS (23.5% vs. 6.9%; aOR 2.27, CI: 1.98-2.61; p < 0.001), HFrEF (20.7% vs. 12.1%; aOR 0.99, CI: 0.88-1.14; p = 0.324), HFpEF (8.8% vs. 4.3%; aOR 1.26, CI: 1.04-1.52; p = 0.020), VU (9.3% vs. 2.1%; aOR 2.56, CI: 2.04-3.20; p < 0.001) AKI (33.2% vs. 9.5%; aOR 2.28, CI: 2.02-2.59; p < 0.001) AF (27.0% vs. 12.9%; aOR 1.74, CI: 1.55-1.97; p < 0.001) BT (17.8% vs. 1.3%; aOR 12.71, CI: 10.07-16.04; p < 0.001). Anemia was associated with increased hospital length of stay (LOS) (10 vs. 4 days; β = 3.9; p < 0.001) and higher THC ($285,660 vs. $114,861; β = $117,902; p < 0.001). Among patients hospitalized with SCAD, anemia was associated with higher risks of hemodynamic compromise, acute kidney injury, atrial fibrillation, and greater resource utilization, although mortality differences were not statistically significant. Recognition of anemia may help identify high-risk SCAD patients needing closer monitoring and tailored management.
自发性冠状动脉剥离(SCAD)是急性冠状动脉综合征的一个日益被认识的原因,特别是在年轻患者和女性中。贫血是心血管疾病患者常见的合并症,可调节SCAD的预后,但其影响仍不明确。我们在全国住院患者样本(2016-2022)中确定了因SCAD住院的成人,并按贫血状况分层。在调整人口统计学、合并症和医院特征的同时,我们构建了多变量logistic回归模型来检验贫血与住院结果之间的关系。主要结局为全因住院死亡率。次要结局包括心脏骤停(CA)、机械循环支持(MCS)、心源性休克(CS)、心力衰竭降低射血分数(HFrEF)、心力衰竭保留射血分数(HFpEF)、输血(BT)、血管增压(VU)、机械通气(MV)、急性肾损伤(AKI)、心房颤动(AF)、住院时间(LOS)和医院总收费(THC)。在63,450名SCAD住院患者中,24.8%患有合并性贫血。贫血患者年龄较大(63.4岁vs 59.7岁),合并症负担较高。虽然两组住院死亡率无显著差异(10.8% vs. 4.6%;调整比值比[aOR] 1.15, 95%可信区间[CI]: 0.96-1.38; p = 0.115),但贫血与MCS的发生率显著升高相关(28.2% vs. 9.5%; aOR 2.64, CI: 2.34-2.99; p = 0.115)
期刊介绍:
The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.
The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis'' integrated format will expand the reader''s knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.